These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 6180005)

  • 1. Mouse bone marrow cells produce a different interferon (IFN) than do spleen cells in response to alloantigens.
    Klimpel GR; Fleischmann WR; Baron S; Klimpel KD
    J Immunol; 1982 Sep; 129(3):946-9. PubMed ID: 6180005
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
    Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutual recognition of parental and F1 lymphocytes. II. Analysis of graft-vs-host-induced suppressor cell activity for T cell-mediated lympholysis to trinitrophenyl self and alloantigens.
    Polisson RP; Shearer GM
    J Immunol; 1980 Oct; 125(4):1865-61. PubMed ID: 6967920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-induced interferon production in canine lymphoid cell cultures.
    Tsai SC; Appel MJ
    Am J Vet Res; 1983 Aug; 44(8):1588-92. PubMed ID: 6194725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone marrow interferon].
    Solov'ev VD; Mentkevich LM; Orlova TG; Shcheglovitova ON; Osidze NG
    Biull Eksp Biol Med; 1975 Jul; 80(7):62-4. PubMed ID: 1227652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivity of hybridomas derived from T cells activated in vivo during graft-versus-host disease.
    Leibnitz RR; Lipsky PE; Thiele DL
    J Immunol; 1994 Dec; 153(11):4959-68. PubMed ID: 7963559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of graft-versus-host disease (GVHD) on host hematopoietic progenitor cells is mediated by Fas-Fas ligand interactions but this does not explain the effect of GVHD on donor cells.
    Iwasaki T; Hamano T; Saheki K; Kuroiwa T; Kataoka Y; Takemoto Y; Ogata A; Sugihara A; Terada N; Fujimoto J; Kakishita E
    Cell Immunol; 1999 Oct; 197(1):30-8. PubMed ID: 10555993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Suppressive effect of xenogenic bone marrow cells on antibody formation in a spleen cell culture in vitro].
    Vlasov AA; Sidorovich IG; Khaitov RM
    Biull Eksp Biol Med; 1980 Jul; 89(7):77-9. PubMed ID: 7407376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Suppressive effect of bone marrow cells from normal and leukemic mice on antibody production in culture of spleen cells in vitro].
    Sidorovich IG; Pcheliniev SIu; Khalmov RM
    Biull Eksp Biol Med; 1980; 89(1):36-8. PubMed ID: 6991020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected role of TNF-alpha in graft versus host reaction (GVHR): donor-derived TNF-alpha suppresses GVHR via inhibition of IFN-gamma-dependent donor type-1 immunity.
    Yamamoto S; Tsuji T; Matsuzaki J; Zhange Y; Chamoto K; Kosaka A; Togashi Y; Sekikawa K; Sawada K; Takeshima T; Koike T; Nishimura T
    Int Immunol; 2004 Jun; 16(6):811-7. PubMed ID: 15126416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel IMPDH inhibitor VX-497 prolongs skin graft survival and improves graft versus host disease in mice.
    Decker CJ; Heiser AD; Chaturvedi PR; Faust TJ; Ku G; Moseley S; Nimmesgern E
    Drugs Exp Clin Res; 2001; 27(3):89-95. PubMed ID: 11447770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrastructural characteristics of Fc epsilon R-positive basophils in the spleen and bone marrow of mice immunized with goat anti-mouse IgD antibody.
    Dvorak AM; Seder RA; Paul WE; Kissell-Rainville S; Plaut M; Galli SJ
    Lab Invest; 1993 Jun; 68(6):708-15. PubMed ID: 8515657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of graft-versus-host disease by a novel immunosuppressant, (5R)-5-hydroxytriptolide (LLDT-8), through expansion of regulatory T cells.
    Tang W; Yang Y; Zhang F; Li YC; Zhou R; Wang JX; Zhu YN; Li XY; Yang YF; Zuo JP
    Int Immunopharmacol; 2005 Dec; 5(13-14):1904-13. PubMed ID: 16275625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease.
    Ushiyama C; Hirano T; Miyajima H; Okumura K; Ovary Z; Hashimoto H
    J Immunol; 1995 Mar; 154(6):2687-96. PubMed ID: 7876541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Suppressive action of bone marrow and spleen cells on antibody genesis and lymphoid cell proliferation in an in vitro culture of autoimmune mice (NZB.NZW)F1].
    Petrov RV; Nasonova VA; Khaitov RM; Nazhmetdinov AM; Pchelintsev SIu
    Tsitologiia; 1981 Jul; 23(7):834-8. PubMed ID: 7281233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity and characterization of cytotoxic cells generated from alloantigen-stimulated murine bone marrow cells.
    Klimpel GR; Klimpel KD
    J Immunol; 1983 Mar; 130(3):1084-9. PubMed ID: 6185569
    [No Abstract]   [Full Text] [Related]  

  • 17. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of lethal, minor-determinate graft-host disease in mice by the in vivo administration of anti-asialo GM1.
    Charley MR; Mikhael A; Bennett M; Gilliam JN; Sontheimer RD
    J Immunol; 1983 Nov; 131(5):2101-3. PubMed ID: 6355291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new strategy for treatment of malignant tumor: intra-bone marrow-bone marrow transplantation plus CD4- donor lymphocyte infusion.
    Suzuki Y; Adachi Y; Minamino K; Zhang Y; Iwasaki M; Nakano K; Koike Y; Ikehara S
    Stem Cells; 2005 Mar; 23(3):365-70. PubMed ID: 15749931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.